PL368563A1 - Sposoby wytwarzania podstawionych 2-(2-pirydylometylo)-sulfinylo-1H-benzimidazoli - Google Patents

Sposoby wytwarzania podstawionych 2-(2-pirydylometylo)-sulfinylo-1H-benzimidazoli

Info

Publication number
PL368563A1
PL368563A1 PL02368563A PL36856302A PL368563A1 PL 368563 A1 PL368563 A1 PL 368563A1 PL 02368563 A PL02368563 A PL 02368563A PL 36856302 A PL36856302 A PL 36856302A PL 368563 A1 PL368563 A1 PL 368563A1
Authority
PL
Poland
Prior art keywords
benzimidazoles
pyridylmethyl
sulfinyl
substituted
processes
Prior art date
Application number
PL02368563A
Other languages
English (en)
Inventor
Ilya Avrutov
Marioara Mendelovici
Original Assignee
Teva Pharmaceutical Industries Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharmaceutical Industries Ltd. filed Critical Teva Pharmaceutical Industries Ltd.
Publication of PL368563A1 publication Critical patent/PL368563A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL02368563A 2001-02-02 2002-02-04 Sposoby wytwarzania podstawionych 2-(2-pirydylometylo)-sulfinylo-1H-benzimidazoli PL368563A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26616201P 2001-02-02 2001-02-02

Publications (1)

Publication Number Publication Date
PL368563A1 true PL368563A1 (pl) 2005-04-04

Family

ID=23013433

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02368563A PL368563A1 (pl) 2001-02-02 2002-02-04 Sposoby wytwarzania podstawionych 2-(2-pirydylometylo)-sulfinylo-1H-benzimidazoli

Country Status (19)

Country Link
US (3) US7129358B2 (pl)
EP (2) EP1363901A4 (pl)
JP (1) JP2004524303A (pl)
KR (1) KR20040029966A (pl)
CN (3) CN100347167C (pl)
CA (1) CA2436467A1 (pl)
CZ (1) CZ20032351A3 (pl)
DE (1) DE02706135T1 (pl)
ES (1) ES2209678T1 (pl)
HR (1) HRP20030691A2 (pl)
HU (1) HUP0303144A3 (pl)
IS (1) IS6897A (pl)
MX (1) MXPA03006904A (pl)
NO (1) NO20033433L (pl)
PL (1) PL368563A1 (pl)
SK (1) SK10792003A3 (pl)
WO (1) WO2002062786A1 (pl)
YU (1) YU61103A (pl)
ZA (1) ZA200305652B (pl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1363901A4 (en) * 2001-02-02 2005-08-31 Teva Pharma PROCESS FOR PREPARING SUBSTITUTED 2- (2-PYRIDYLMETHYL) SULFINYL-1H-BENZIMIDAZOLENE
EP1476442A2 (en) * 2002-03-27 2004-11-17 Teva Pharmaceutical Industries Ltd. Lansoprazole polymorphs and processes for preparation thereof
WO2004011455A1 (en) * 2002-07-26 2004-02-05 Teva Pharmaceutical Industries Ltd. Preparation of lansoprazole and related compounds
EP1501824B1 (en) * 2002-08-21 2007-10-10 Teva Pharmaceutical Industries Ltd A method for the purification of lansoprazole
WO2004046135A1 (en) * 2002-11-18 2004-06-03 Teva Pharmaceutical Industries Ltd. Stable lansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol
EP1572680A2 (en) 2002-12-19 2005-09-14 Eva Pharmaceutical Industries Ltd. Solid states of pantoprazole sodium, known pantoprazole sodium hydrates, processes for their preparation.
WO2004072061A1 (en) * 2003-02-05 2004-08-26 Teva Pharmaceutical Industries Ltd. Method of stabilizing lansoprazole
US20040235904A1 (en) * 2003-03-12 2004-11-25 Nina Finkelstein Crystalline and amorphous solids of pantoprazole and processes for their preparation
US7683177B2 (en) * 2003-06-10 2010-03-23 Teva Pharmaceutical Industries Ltd Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole
FR2871800B1 (fr) * 2004-06-17 2006-08-25 Sidem Pharma Sa Sa Sel de sodium monohydrate du s-tenatoprazole et application en therapeutique
JP5355893B2 (ja) * 2004-12-16 2013-11-27 シプラ・リミテッド パントプラゾールナトリウムの製造方法
EP1681056A1 (en) * 2005-01-14 2006-07-19 Krka Tovarna Zdravil, D.D., Novo Mesto Process for preparing lansoprazole
CA2607583A1 (en) * 2005-05-06 2007-04-05 Medichem, S.A. Pantoprazole free acid form iii
CN1919844B (zh) * 2006-09-01 2010-05-12 武汉工程大学 水相氧化合成兰索拉唑的方法
US20100113527A1 (en) * 2008-09-30 2010-05-06 Teva Pharmaceutical Industries Ltd. Crystalline forms of dexlansoprazole
WO2010134099A1 (en) * 2009-05-21 2010-11-25 Cadila Healthcare Limited One pot process for preparing omeprazole and related compounds
CN108623564B (zh) * 2017-03-17 2022-11-04 江苏豪森药业集团有限公司 一种雷贝拉唑类似物的制备方法
CN111072633A (zh) * 2019-12-19 2020-04-28 山东达因海洋生物制药股份有限公司 一种埃索美拉唑镁三水合物的制备方法
CN112174934B (zh) * 2020-10-15 2023-12-22 成都百泉生物医药科技有限公司 一种奥美拉唑的合成方法及其合成设备

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1140119A (en) 1978-04-03 1983-01-25 Joseph Torremans N-heterocyclyl-4-piperidinamines
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
GB2069492B (en) 1980-02-20 1984-02-29 Wyeth John & Brother Ltd Sulphur compounds
SE8300736D0 (sv) * 1983-02-11 1983-02-11 Haessle Ab Novel pharmacologically active compounds
DK171989B1 (da) * 1987-08-04 1997-09-08 Takeda Chemical Industries Ltd Fremgangsmåde til fremstilling af 2-(2-pyridylmethylsulfinyl)-benzimidazoler
SE9002043D0 (sv) * 1990-06-07 1990-06-07 Astra Ab Improved method for synthesis
NZ244301A (en) * 1991-09-20 1994-08-26 Merck & Co Inc Preparation of 2-pyridylmethylsulphinylbenzimidazole and pyridoimidazole derivatives from the corresponding sulphenyl compounds
ES2063705B1 (es) * 1993-06-14 1995-07-16 S A L V A T Lab Sa Intermedio para la sintesis de lansoprazol y su procedimiento de obtencion.
SK283805B6 (sk) * 1996-09-09 2004-02-03 Slovakofarma, A. S. Spôsob prípravy omeprazolu
SE9704183D0 (sv) 1997-11-14 1997-11-14 Astra Ab New process
EP1371361B1 (en) * 1997-12-08 2011-03-09 Nycomed GmbH Novel suppository form comprising an acid-labile active compound
GB9805558D0 (en) * 1998-03-17 1998-05-13 Knoll Ag Chemical process`
US6303787B1 (en) * 1998-05-27 2001-10-16 Natco Pharma Limited Intermediates and an improved process for the preparation of Omeprazole employing the said intermediates
SI20019A (sl) * 1998-07-13 2000-02-29 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Izboljšan postopek sinteze 5-metoksi -2-/(4-metoksi-3,5-dimetil-2-piridil)metil/ sulfinil-1H-benzimidazola
JP4047993B2 (ja) * 1999-01-04 2008-02-13 理想科学工業株式会社 孔版印刷方法
US6245913B1 (en) * 1999-06-30 2001-06-12 Wockhardt Europe Limited Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
ES2163372B1 (es) * 2000-03-13 2003-05-01 Esteve Quimica Sa Procedimiento de oxidacion de un grupo tioeter a sulfoxido.
EP1363901A4 (en) 2001-02-02 2005-08-31 Teva Pharma PROCESS FOR PREPARING SUBSTITUTED 2- (2-PYRIDYLMETHYL) SULFINYL-1H-BENZIMIDAZOLENE

Also Published As

Publication number Publication date
CZ20032351A3 (cs) 2004-08-18
HUP0303144A2 (hu) 2004-03-01
CN1781918A (zh) 2006-06-07
SK10792003A3 (sk) 2004-07-07
CN1489585A (zh) 2004-04-14
CA2436467A1 (en) 2002-08-15
CN100347167C (zh) 2007-11-07
IS6897A (is) 2003-07-29
HRP20030691A2 (en) 2005-04-30
WO2002062786A1 (en) 2002-08-15
CN1876647A (zh) 2006-12-13
EP1363901A4 (en) 2005-08-31
EP1363901A1 (en) 2003-11-26
US20030036554A1 (en) 2003-02-20
NO20033433D0 (no) 2003-08-01
US7129358B2 (en) 2006-10-31
ES2209678T1 (es) 2004-07-01
ZA200305652B (en) 2004-07-22
DE02706135T1 (de) 2004-05-19
HUP0303144A3 (en) 2007-08-28
KR20040029966A (ko) 2004-04-08
EP1970374A1 (en) 2008-09-17
US20080091024A1 (en) 2008-04-17
YU61103A (sh) 2006-05-25
NO20033433L (no) 2003-09-25
US20060293363A1 (en) 2006-12-28
JP2004524303A (ja) 2004-08-12
MXPA03006904A (es) 2004-12-06

Similar Documents

Publication Publication Date Title
HRP20030691A2 (en) Processes for the production of substituted 2-(2-pyridylmethyl)sulfinyl-benzimidazoles
EG22541A (en) Process for the production of olefins
IL143106A (en) Process for the preparation of diphenylmethylthioacetamide
IL154803A0 (en) New process for the production of oxabispidines
IL159304A0 (en) Process for the production of piperidine derivatives
EG23204A (en) Process for the production of quinazolines.
EG24033A (en) Process for the production of olefins
HUP0303025A3 (en) Process for the preparation of arylethanoldiamines
AU2002335992A1 (en) Process for the production of ascopyrone p
IL158119A0 (en) Method for the production of delta1-pyrrolines
PL366904A1 (pl) Sposób wytwarzania poliizocyjanianów w procesie ciągłym
IL160252A0 (en) Hydrates of optionally substituted 2-(2-pyridinyl) methylthio-1h-benzimidazoles and method for the production thereof
HK1058517A (en) Processes for the production of substituted 2-(2-pyridylmethyl) sulfinyl-1h-benzimidazoles
GC0000365A (en) Process for the production of olefins
FI20012552A0 (fi) Metallikarbonaatin valmistusmenetelmä
AU2002352014A1 (en) Method for the production of organodiphosphonites
SI1399437T1 (en) Method for the production of triazolylmethylepoxides
AU2002240925A1 (en) Process for the production of 6-methylheptanone
AU2002337120A1 (en) Method for the production of 1-octene by reductive telomerisation
AU2002314365A1 (en) Process for the production of allicin
HU0104286D0 (en) Process for producing 2-(benzyloxi)imino-malonic acid derivatives and the novel derivatives
AU2002251114A1 (en) Process for the production of xylose
GB0105878D0 (en) Novel process for the preparation of pyrazoloprimidinones
GB0007768D0 (en) Process for the production of olefins
SI1421076T1 (sl) Hidrati po zelji substituiranih 2-(2-piridinil)metiltio-1H-benzimidazolov in postopek za njihovo pripravo

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)